IPO Ideas
Mahamaya Lifesciences Limited IPO logo

Mahamaya Lifesciences Limited IPO

FPSMEBSEListed
Listed at
116
+0.00%

Mahamaya Lifesciences Limited IPO is a SME fixed price IPO. Issue size is 70.44 Cr. Price band is ₹108 to ₹114 per share. Minimum investment is ₹2.78 L. Lot size is 1200 shares. Open from 11 Nov 2025 to 13 Nov 2025. Allotment on 14 Nov 2025. Listing on 18 Nov 2025 at BSE. Managed by Oneview Corporate Advisors Pvt.Ltd.. Registrar: Kfin Technologies Limited. Key details for GMP, subscription, price, allotment, and listing in one place.

Official documents: RHP and DRHP.

Mahamaya Lifesciences Limited IPO overview

Mahamaya Lifesciences Limited IPO Key figures

Price band, lot, minimum application, and issue window at a glance.

Price band
₹108 to ₹114
Lot size
1200 shares / lot
Min investment
₹2,78,400
Issue open – close
11 Nov 2025 → 13 Nov 2025

Mahamaya Lifesciences Limited IPO important dates

Issue Opens
11 Nov 2025
Issue Closes
13 Nov 2025
Allotment
14 Nov 2025
Listing
18 Nov 2025

Mahamaya Lifesciences Limited IPO lot size

CategoryLotsSharesAmount
Retail (Min)22,4002,78,400
S-HNI (Min)33,6004,17,600
S-HNI (UPI)33,6004,17,600
S-HNI (Max)78,4009,74,400
B-HNI (Min)89,60011,13,600

About Mahamaya Lifesciences Limited IPO

From the company / RHP narrative.

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in manufacturing, registration and export of finest crop protection products and bioproducts for crop & soil health management and to help the farming community for more productivity.

The company specializes in manufacturing pesticide formulations and supplying bulk products to Indian agrochemical companies and multinational corporations (MNCs).

The company imports carefully researched molecules, registers them with the Central Insecticides Board, and markets them as technical and value-added formulations for domestic manufacturers and multinational corporations (MNCs).

The company has invested in global product registrations, with active markets in countries like the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey, offering high-quality products and data support for registrations.

Product Portfolio:


Bulk Formulations Sales: Acetamiprid, SP Buprofezin, SC Emamectin benzoate, SG Imidacloprid, SC Paraquat Dichloride.
Technical Sales: Acetamiprid Technical 99% Min, Atrazine Technical 95% Min, Imidacloprid Technical 95% Min, Emamectin Benzoate Technical 95% Min.
Branded Sales (Major own branded products): MAYAMRIT GR, MAYAMRIT SL, MAYAGIBB, UCHIT EW 370
Export Sales- Formulations: Wiper (Sulphur 80% WDG), Lancha (Pendimethalin 50% EC), Tolfen (Tolfenpyrad 15% EC), Typic (80% Sulphur WG).


Competitive Strengths:


Experienced management team consisting of experts.
Capability to introduce vital products for Indian Agriculture.
Development of export opportunities of products.
Ability to develop brands.
Cordial relationships with suppliers of raw materials.
Core values focused on achieving sustainability through innovative approaches.

Objective of the issue

How the issuer plans to use IPO proceeds.

Purchase of Equipment for existing Formulation plant

Funding capital expenditure towards setting up of a new technical manufacturing plant

Construction of Warehouse Building and Purchase of Machinery

Funding working capital requirement of our Company

General Corporate purposes
Mahamaya Lifesciences Limited IPO FAQs
A quick overview of key terms, dates, and how to track this IPO.

Documents & links

Prospectus, draft filings, and company site open in a new tab.

Registrar

Details about the registrar of the issue.

Registrar Name
Kfin Technologies Limited
Phone
4067162222
Address
KFintech, Tower-B, Plot No 31 & 32, Financial District, Nanakramguda, Gachibowli, Hyderabad, Telangana India - 500 032.

Issue details

Key details about the issue, including the face value, lot size, and minimum investment.

Issue Type
FP
Face Value
10
Lead Managers
Oneview Corporate Advisors Pvt.Ltd.
Min Quantity
2,400
Company Promoters
Mr. Krishnamurthy Ganesan,Mrs. Lalitha Krishnamurthy,,Mr. Prashant Krishnamurthy are the Promoters of the company.
Phone
+91-1146561474
Address
Mahamaya Lifesciences Ltd. Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020

Related articles

Research posts and updates that reference this company or theme.

Follow IPO & unlisted research in the app, available on iOS and Android.